Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CUE will decline by -25.02% over the next 2 Weeks and hit $0.27 by Friday, January 23, 2026. In that time frame, CUE's share price is expected to range between $0.19 and $0.35.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jan 23, 2026 | 0.18 | 0.27 | 0.35 |
| Jan 22, 2026 | 0.22 | 0.31 | 0.39 |
| Jan 21, 2026 | 0.20 | 0.28 | 0.36 |
| Jan 20, 2026 | 0.20 | 0.28 | 0.36 |
| Jan 19, 2026 | 0.22 | 0.30 | 0.39 |
| Jan 16, 2026 | 0.22 | 0.31 | 0.40 |
| Jan 15, 2026 | 0.28 | 0.35 | 0.44 |
| Jan 14, 2026 | 0.24 | 0.33 | 0.42 |
| Jan 13, 2026 | 0.25 | 0.33 | 0.41 |
| Jan 12, 2026 | 0.26 | 0.35 | 0.43 |
CUE shares fell -8.25% in Friday, January 9, 2026's trading session, dropping from a previous close of $0.39 to move at $0.36. The stock demonstrated notable intraday movement (see CUE's key stats for a full breakdown), fluctuating between $0.34 and $0.40, a +17.59% trading range. While recent weeks have seen some volatility, CUE has managed to secure a +10.99% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 877K shares changing hands, 345.54K more than the previous session. This amounted to $316.16K in total market activity.
Will CUE Continue Its Downward Trend?
According to analyst ratings and projections for CUE, Cue Biopharma, Inc. shares are anticipated to decrease by -2.88%, potentially reaching $0.35 per share by January 23, 2026. Short-term technical indicators for CUE currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the CUE stock forecast, now is not the best time to buy CUE stock because its current trading price is +35.58% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CUE covering social and institutional perspectives.
CUE Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CUE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.90% to 47.97%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 40.81%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.88%, maintains a neutral outlook for the long term. Insights into CUE's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Cue Biopharma Short-Term Forecasts
CUE Forecast For Next 5 Days
Our algorithm anticipates Cue Biopharma (CUE) stock could hit $0.21 by Jan 08, 2026. This represents a -40.92% rise from today's price, following a +28.65% change over the past five days.
CUE Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Cue Biopharma, Inc. (CUE) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.17, which would mean a -52.84% decrease from the current price of $0.36. Projections for this period range from a high of $0.31 to a low of $0.06.
CUE Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Cue Biopharma's price over the next three months point to a rise. CUE stock is expected to peak at $2.54 on Jan 16, 2026 before potentially dipping to $0.05 on Mar 02, 2026. On average, CUE is likely to trade around $1.29 in the coming 90 days.
Cue Biopharma Stock Forecast 2025
Based on our predictive models, Cue Biopharma (CUE) is expected to trade between $0.00 and $3.17 throughout 2026. This would result in an average price of $1.37, potentially offering investors a +280.03% return from current levels.
Cue Biopharma, Inc. Monthly Forecast 2026
January 2026
According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in January 2026. The price is predicted to move between $1.57 and $2.54, settling at an average of $2.14. This could translate to a +493.62% gain.
February 2026
Based on current market signals, Cue Biopharma, Inc. is projected to trend february 2026. We forecast a trading range from $0.06 to $1.75, with a likely average price of $0.77. Investors could expect a potential return of +113.59%.
March 2026
Our predictive algorithms indicate Cue Biopharma, Inc. stock may see a shift in March 2026. The expected range spans $0.05–$1.84, with an average target of $1.08. This represents a positive outlook and a possible gain of +199.58%.
April 2026
Analyzing established trends, Cue Biopharma, Inc. looks set to move in April 2026. Projections place the stock between $0.68 and $1.72, averaging around $1.15. This suggests a +219.00% gain from current levels.
May 2026
Market indicators suggest Cue Biopharma, Inc. could experience notable changes during May 2026. Prices could fluctuate within $1.30 to $2.92, with a midpoint forecast of $2.06. The stock might deliver a +471.43% gain.
June 2026
Forecasting for June 2026, models estimate that Cue Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.45 and $3.17, averaging $2.86. This signals a positive trajectory with potential returns around +693.34%.
July 2026
According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.63 and $2.15, settling at an average of $1.64. This could translate to a +354.92% gain.
August 2026
Based on current market signals, Cue Biopharma, Inc. is projected to trend august 2026. We forecast a trading range from $0.47 to $1.70, with a likely average price of $1.44. Investors could expect a potential return of +299.45%.
September 2026
Our predictive algorithms indicate Cue Biopharma, Inc. stock may see a shift in September 2026. The expected range spans $0.00–$1.20, with an average target of $0.27. This represents a cautious outlook and a possible loss of -25.10%.
October 2026
Analyzing established trends, Cue Biopharma, Inc. looks set to move in October 2026. Projections place the stock between $0.00 and $1.75, averaging around $0.52. This suggests a +44.24% gain from current levels.
November 2026
Market indicators suggest Cue Biopharma, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.04 to $2.56, with a midpoint forecast of $1.90. The stock might deliver a +427.05% gain.
December 2026
Forecasting for December 2026, models estimate that Cue Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.18, averaging $0.62. This signals a positive trajectory with potential returns around +71.98%.
CUE's history of dividends and stock splits also plays a role in long-term investor confidence.

